ALSO NOTED: Microsoft wins Australian contract; Hopkins caves on skin cream; and much more...

> Microsoft has won a $36 million contract to upgrade Australia's e-health infrastructure and build a platform for the country's electronic medical record system. Article [1]

> Guidant's first trial over one of its faulty defibrillators has been postponed. Article [2]

> Johns Hopkins said it is removing its name from a product made by a skin care care company. Article [3]

> Abbott Laboratories CEO Miles White talks with The Wall Street Journal about his company's plans to acquire Guidant's stent business. Video [4]

> Ah, politics. With New York Attorney General Eliot Spitzer a leading candidate in the governor's race, his opponent is attacking his record fighting Medicaid fraud. Article [5]

> The International Federation of Pharmaceutical Manufacturers and IBM announced they will launch a clinical trials portal that will help physicians and patients find experimental treatments. Article [6]

> The FBI said it is investigating the transplant program at troubled University of California Irvine Medical Center. Article [7]

> Health Affairs has a series of articles out showing that community initiatives to solve the uninsurance problem don't work too well. Release [8]

> Swedish construction group Skanska scores a $1.7 billion contract to St. Bartholomew's Hospital and The Royal London Hospital in the U.K. Article [9]

And Finally... Do non-profit hospitals have any business running for-profit subsidiaries? The Cleveland Plain Dealer wonders if the parking garage at the Cleveland Clinic is a betrayal of the public trust. Article [10]